Surgical Innovations ( (GB:SUN) ) has provided an announcement.
Surgical Innovations Group plc has announced an update on its financial expectations for the fiscal year ending December 31, 2024. The company anticipates reporting revenues of at least £11.8 million and an adjusted EBITDA ranging from £0.0 million to £0.4 million. The company remains on track to release its full-year results in May 2025, indicating steady progress in its operations and financial performance.
More about Surgical Innovations
Surgical Innovations Group plc specializes in designing, manufacturing, and distributing innovative medical products primarily for minimally invasive surgery. Their offerings include branded port access systems, surgical instruments, and retraction devices, which are marketed in the UK through Elemental Healthcare and globally via distribution partners. The company focuses on ‘resposable’ products that combine reusable and disposable elements, providing cost-effective and environmentally friendly solutions. Additionally, they have exclusive UK distribution for specialized surgical products and collaborate with OEM partners and industrial entities for precision engineering solutions.
YTD Price Performance: -9.09%
Average Trading Volume: 2,757,356
Technical Sentiment Signal: Strong Buy
Current Market Cap: £4.66M
For a thorough assessment of SUN stock, go to TipRanks’ Stock Analysis page.